Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
18%

OVERLAP
BY WEIGHT
15

# OF OVERLAPPING
HOLDINGS
SBIO
84
HOLDINGS
18%
ALSO IN XPH
XPH
58
HOLDINGS
26%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus XPH)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in SBIO
Weight
in XPH
Overlap
DEFINIUM THERAPEUTICS INC 2.5% 2.7% 2.5%
EDGEWISE THERAPEUTICS, INC. 2.8% 2.2% 2.2%
AMYLYX PHARMACEUTICALS, INC. 2.1% 3.8% 2.1%
TARSUS PHARMACEUTICALS, INC. 2.0% 2.1% 2.0%
VERADERMICS INC 2.4% 1.7% 1.7%
SBIO Overweight Relative to XPH
CG ONCOLOGY, INC. 3.8%
TRAVERE THERAPEUTICS, INC. 3.6%
DIANTHUS THERAPEUTICS INC 3.4%
ORUKA THERAPEUTICS INC 3.3%
ACADIA PHARMACEUTICALS INC 2.8%
RELAY THERAPEUTICS, INC. 2.4%
DENALI THERAPEUTICS INC. 2.0%
IDEAYA BIOSCIENCES, INC. 2.0%
DYNE THERAPEUTICS INC 1.8%
CELLDEX THERAPEUTICS INC 1.7%
SBIO Underweight Relative to XPH
OMEROS CORP -2.9%
ENLIVEN THERAPEUTICS, INC. -2.4%
CORCEPT THERAPEUTICS INC -2.3%
ETON PHARMACEUTICALS, INC. -2.2%
PERRIGO CO -2.0%
MERCK & CO. INC. -2.0%
OCULAR THERAPEUTIX INC -2.0%
TREVI THERAPEUTICS, INC. -1.9%
HARMONY BIOSCIENCES HOLDINGS, INC. -1.9%
LIGAND PHARMACEUTICALS-CL B -1.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY